New

Congenital Heart Disease Treatment Market

2021

Congenital Heart Disease Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Medication, Surgical Therapy); End user (Hospitals and Clinics, Diagnostic Centers) and Geography

| Report Code: TIPRE00017800 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Congenital Heart Disease Treatment Market 2028 By Type, End user and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Congenital heart disease, also known as congenital heart defect (CHD), is a malformed or undeveloped heart present at birth. Symptoms can vary from none to life-threatening. When present, they may include low weight gain, rapid breathing, cyanosis, and fatigue. Complications that can result from heart defects include heart failure.

MARKET DYNAMICS

The factors driving the global congenital heart disease treatment market's growth are the rising prevalence of congenital heart disease and the rise in the adoption of minimally invasive procedures. Further, many dominating market players, growing demand for catheterization, and application of cardiac biomarkers in congenital heart disease treatment are also considered a significant factor for driving the growth of the global congenital heart disease market during the forecast period. However, the high costs of congenital heart disease treatment will hamper the market growth.

MARKET SCOPE

The "Congenital Heart Disease Treatment Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of congenital heart disease treatment market with detailed market segmentation with type, and end user. The congenital heart disease treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in congenital heart disease treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The congenital heart disease treatment market is segmented on the basis of type and end user. On the basis of type, the congenital heart disease treatment market is divided into medication and surgical therapy. Based on end user, congenital heart disease treatment market can be segmented as hospitals and clinics, and diagnostic centres.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the congenital heart disease treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The congenital heart disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting congenital heart disease treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the congenital heart disease treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments congenital heart disease treatment market anal cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from congenital heart disease treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for congenital heart disease treatment in the global market. Below mentioned is the list of few companies engaged in the congenital heart disease treatment market.

The report also includes the profiles of key players in congenital heart disease treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Merck and Co. Inc.
  •  Pfizer Inc.
  •  Amgen Inc.
  •  Abbott Laboratories
  •  Sanofi S.A.
  •  GlaxoSmithKline plc
  •  Eli Lilly and Company
  •  AstraZeneca plc
  •  Medtronic plc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Congenital Heart Disease Treatment Market - By Type
1.3.2 Congenital Heart Disease Treatment Market - By End user
1.3.3 Congenital Heart Disease Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CONGENITAL HEART DISEASE TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CONGENITAL HEART DISEASE TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CONGENITAL HEART DISEASE TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. CONGENITAL HEART DISEASE TREATMENT - GLOBAL MARKET OVERVIEW
6.2. CONGENITAL HEART DISEASE TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CONGENITAL HEART DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICATION
7.3.1. Overview
7.3.2. Medication Market Forecast and Analysis
7.4. SURGICAL THERAPY
7.4.1. Overview
7.4.2. Surgical Therapy Market Forecast and Analysis
8. CONGENITAL HEART DISEASE TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and Clinics Market Forecast and Analysis
8.4. DIAGNOSTIC CENTERS
8.4.1. Overview
8.4.2. Diagnostic Centers Market Forecast and Analysis

9. CONGENITAL HEART DISEASE TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Congenital Heart Disease Treatment Market Overview
9.1.2 North America Congenital Heart Disease Treatment Market Forecasts and Analysis
9.1.3 North America Congenital Heart Disease Treatment Market Forecasts and Analysis - By Type
9.1.4 North America Congenital Heart Disease Treatment Market Forecasts and Analysis - By End user
9.1.5 North America Congenital Heart Disease Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Congenital Heart Disease Treatment Market
9.1.5.1.1 United States Congenital Heart Disease Treatment Market by Type
9.1.5.1.2 United States Congenital Heart Disease Treatment Market by End user
9.1.5.2 Canada Congenital Heart Disease Treatment Market
9.1.5.2.1 Canada Congenital Heart Disease Treatment Market by Type
9.1.5.2.2 Canada Congenital Heart Disease Treatment Market by End user
9.1.5.3 Mexico Congenital Heart Disease Treatment Market
9.1.5.3.1 Mexico Congenital Heart Disease Treatment Market by Type
9.1.5.3.2 Mexico Congenital Heart Disease Treatment Market by End user
9.2. EUROPE
9.2.1 Europe Congenital Heart Disease Treatment Market Overview
9.2.2 Europe Congenital Heart Disease Treatment Market Forecasts and Analysis
9.2.3 Europe Congenital Heart Disease Treatment Market Forecasts and Analysis - By Type
9.2.4 Europe Congenital Heart Disease Treatment Market Forecasts and Analysis - By End user
9.2.5 Europe Congenital Heart Disease Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Congenital Heart Disease Treatment Market
9.2.5.1.1 Germany Congenital Heart Disease Treatment Market by Type
9.2.5.1.2 Germany Congenital Heart Disease Treatment Market by End user
9.2.5.2 France Congenital Heart Disease Treatment Market
9.2.5.2.1 France Congenital Heart Disease Treatment Market by Type
9.2.5.2.2 France Congenital Heart Disease Treatment Market by End user
9.2.5.3 Italy Congenital Heart Disease Treatment Market
9.2.5.3.1 Italy Congenital Heart Disease Treatment Market by Type
9.2.5.3.2 Italy Congenital Heart Disease Treatment Market by End user
9.2.5.4 Spain Congenital Heart Disease Treatment Market
9.2.5.4.1 Spain Congenital Heart Disease Treatment Market by Type
9.2.5.4.2 Spain Congenital Heart Disease Treatment Market by End user
9.2.5.5 United Kingdom Congenital Heart Disease Treatment Market
9.2.5.5.1 United Kingdom Congenital Heart Disease Treatment Market by Type
9.2.5.5.2 United Kingdom Congenital Heart Disease Treatment Market by End user
9.2.5.6 Rest of Europe Congenital Heart Disease Treatment Market
9.2.5.6.1 Rest of Europe Congenital Heart Disease Treatment Market by Type
9.2.5.6.2 Rest of Europe Congenital Heart Disease Treatment Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Congenital Heart Disease Treatment Market Overview
9.3.2 Asia-Pacific Congenital Heart Disease Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Congenital Heart Disease Treatment Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Congenital Heart Disease Treatment Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Congenital Heart Disease Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Congenital Heart Disease Treatment Market
9.3.5.1.1 Australia Congenital Heart Disease Treatment Market by Type
9.3.5.1.2 Australia Congenital Heart Disease Treatment Market by End user
9.3.5.2 China Congenital Heart Disease Treatment Market
9.3.5.2.1 China Congenital Heart Disease Treatment Market by Type
9.3.5.2.2 China Congenital Heart Disease Treatment Market by End user
9.3.5.3 India Congenital Heart Disease Treatment Market
9.3.5.3.1 India Congenital Heart Disease Treatment Market by Type
9.3.5.3.2 India Congenital Heart Disease Treatment Market by End user
9.3.5.4 Japan Congenital Heart Disease Treatment Market
9.3.5.4.1 Japan Congenital Heart Disease Treatment Market by Type
9.3.5.4.2 Japan Congenital Heart Disease Treatment Market by End user
9.3.5.5 South Korea Congenital Heart Disease Treatment Market
9.3.5.5.1 South Korea Congenital Heart Disease Treatment Market by Type
9.3.5.5.2 South Korea Congenital Heart Disease Treatment Market by End user
9.3.5.6 Rest of Asia-Pacific Congenital Heart Disease Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Congenital Heart Disease Treatment Market by Type
9.3.5.6.2 Rest of Asia-Pacific Congenital Heart Disease Treatment Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Congenital Heart Disease Treatment Market Overview
9.4.2 Middle East and Africa Congenital Heart Disease Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Congenital Heart Disease Treatment Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Congenital Heart Disease Treatment Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Congenital Heart Disease Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Congenital Heart Disease Treatment Market
9.4.5.1.1 South Africa Congenital Heart Disease Treatment Market by Type
9.4.5.1.2 South Africa Congenital Heart Disease Treatment Market by End user
9.4.5.2 Saudi Arabia Congenital Heart Disease Treatment Market
9.4.5.2.1 Saudi Arabia Congenital Heart Disease Treatment Market by Type
9.4.5.2.2 Saudi Arabia Congenital Heart Disease Treatment Market by End user
9.4.5.3 U.A.E Congenital Heart Disease Treatment Market
9.4.5.3.1 U.A.E Congenital Heart Disease Treatment Market by Type
9.4.5.3.2 U.A.E Congenital Heart Disease Treatment Market by End user
9.4.5.4 Rest of Middle East and Africa Congenital Heart Disease Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Congenital Heart Disease Treatment Market by Type
9.4.5.4.2 Rest of Middle East and Africa Congenital Heart Disease Treatment Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Congenital Heart Disease Treatment Market Overview
9.5.2 South and Central America Congenital Heart Disease Treatment Market Forecasts and Analysis
9.5.3 South and Central America Congenital Heart Disease Treatment Market Forecasts and Analysis - By Type
9.5.4 South and Central America Congenital Heart Disease Treatment Market Forecasts and Analysis - By End user
9.5.5 South and Central America Congenital Heart Disease Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Congenital Heart Disease Treatment Market
9.5.5.1.1 Brazil Congenital Heart Disease Treatment Market by Type
9.5.5.1.2 Brazil Congenital Heart Disease Treatment Market by End user
9.5.5.2 Argentina Congenital Heart Disease Treatment Market
9.5.5.2.1 Argentina Congenital Heart Disease Treatment Market by Type
9.5.5.2.2 Argentina Congenital Heart Disease Treatment Market by End user
9.5.5.3 Rest of South and Central America Congenital Heart Disease Treatment Market
9.5.5.3.1 Rest of South and Central America Congenital Heart Disease Treatment Market by Type
9.5.5.3.2 Rest of South and Central America Congenital Heart Disease Treatment Market by End user

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. CONGENITAL HEART DISEASE TREATMENT MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK AND CO. INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AMGEN INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ABBOTT LABORATORIES
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SANOFI S.A.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ELI LILLY AND COMPANY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ASTRAZENECA PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MEDTRONIC PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Novartis AG
2. Merck and Co. Inc.
3. Pfizer Inc.
4. Amgen Inc.
5. Abbott Laboratories
6. Sanofi S.A.
7. GlaxoSmithKline plc
8. Eli Lilly and Company
9. AstraZeneca plc
10. Medtronic plc
TIPRE00017800
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.